Jiangsu CoWin Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	255.47	348.34	1,032	127.83
Short-Term Investments	-	60.54	90.01	-	-
Trading Asset Securities	-	417.04	545.28	402.59	233.42
Cash & Short-Term Investments	611.02	733.05	983.64	1,434	361.25
Cash Growth	-16.65%	-25.48%	-31.41%	297.00%	5.63%
Accounts Receivable	-	43.28	58.96	129.64	36.56
Other Receivables	-	-	-	0.31	-
Receivables	-	43.28	58.96	129.95	36.56
Inventory	-	45.87	32.04	52.53	32.62
Other Current Assets	-	11.21	10.04	10.05	7.72
Total Current Assets	-	833.4	1,085	1,627	438.16
Property, Plant & Equipment	-	381.13	394.39	246.43	159.44
Long-Term Investments	-	296.81	256.71	-	-
Goodwill	-	1.08	-	4.27	-
Other Intangible Assets	-	49.97	29.77	29.35	30.15
Long-Term Deferred Tax Assets	-	32.5	29.83	17.11	4
Long-Term Deferred Charges	-	20.73	24.8	11.36	13.82
Other Long-Term Assets	-	2.52	2.04	20.06	3.2
Total Assets	-	1,618	1,822	1,955	648.77
Accounts Payable	-	31.86	47.53	44.07	10.55
Accrued Expenses	-	18.51	16.69	21.69	22.12
Short-Term Debt	-	6.01	-	-	-
Current Portion of Leases	-	12.12	13.65	9.05	5.67
Current Income Taxes Payable	-	-	-	9.56	8.21
Current Unearned Revenue	-	9.63	4.48	5.75	10.28
Other Current Liabilities	-	5.87	2.51	3.03	3.58
Total Current Liabilities	-	84	84.86	93.15	60.41
Long-Term Leases	-	9.71	19.31	31.72	34.33
Long-Term Unearned Revenue	-	30.25	30.11	29.58	5.67
Long-Term Deferred Tax Liabilities	-	7.75	8.32	9.1	0.06
Other Long-Term Liabilities	-	0.09	0.06	0.05	0.04
Total Liabilities	-	131.79	142.67	163.6	100.51
Common Stock	-	112.49	112.23	93.52	69.87
Additional Paid-In Capital	-	1,394	1,391	1,393	344.45
Retained Earnings	-	2.87	160.08	293.13	133.87
Treasury Stock	-	-43.66	-	-	-
Comprehensive Income & Other	-	0.33	0.3	0.27	0.07
Total Common Equity	1,391	1,466	1,664	1,780	548.26
Minority Interest	-	20.56	15.88	11.31	-
Shareholders' Equity	1,409	1,486	1,680	1,792	548.26
Total Liabilities & Equity	-	1,618	1,822	1,955	648.77
Total Debt	22.25	27.84	32.95	40.77	39.99
Net Cash (Debt)	588.77	705.21	950.68	1,393	321.25
Net Cash Growth	-16.51%	-25.82%	-31.77%	333.73%	-6.07%
Net Cash Per Share	5.36	6.32	8.45	15.00	3.81
Filing Date Shares Outstanding	108.37	110.11	112.49	112.23	83.85
Total Common Shares Outstanding	109.93	110.11	112.23	112.23	83.85
Working Capital	-	749.41	999.82	1,534	377.75
Book Value Per Share	12.65	13.31	14.82	15.86	6.54
Tangible Book Value	1,341	1,415	1,634	1,747	518.11
Tangible Book Value Per Share	12.20	12.85	14.56	15.56	6.18
Buildings	-	235.28	234.89	0.66	0.66
Machinery	-	207.97	188.41	133.11	75.91
Construction In Progress	-	0.37	-	110.9	64.81

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.